Capital Clinical Research Associates

Rockville, Maryland 20852

0 studies enrolling now · 12 studies all time

What they study most

Anxiety Disorder, Bipolar Disorder, Bipolar I Depression, Fibromyalgia, Generalized Anxiety Disorder, Major Depressive Disorder, Seasonal Affective Disorder, Social Phobia

Studies at this site

• A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode — Completed
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) — Completed
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder — Completed
• Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD) — Completed
• A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder — Completed
• Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD) — Completed
• Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD) — Completed
• A Study of CX157 (TriRima) for the Treatment of Depression — Completed
• Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder — Completed
• A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. — Completed
• Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder — Completed